Swiss Re AG (LON:0QL6)
145.91
-0.13 (-0.09%)
At close: Jul 31, 2025
Theseus Pharmaceuticals Market Cap
Swiss Re AG has a market cap or net worth of 40.68 billion as of August 1, 2025. Its market cap has increased by 46.74% in one year.
Market Cap
40.68B
Enterprise Value
43.69B
Revenue
33.93B
Ranking
n/a
PE Ratio
15.67
Stock Price
$145.91
Market Cap Chart
Since May 2, 1996, Swiss Re AG's market cap has increased from 10.21B to 40.68B, an increase of 298.48%. That is a compound annual growth rate of 4.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 40.68B | 20.64% |
Dec 30, 2024 | 33.72B | 31.70% |
Dec 29, 2023 | 25.60B | 14.15% |
Dec 30, 2022 | 22.43B | 6.10% |
Dec 30, 2021 | 21.14B | 9.26% |
Dec 30, 2020 | 19.35B | -21.62% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HSBC Holdings | 168.02B |
London Stock Exchange Group | 52.64B |
Barclays | 52.25B |
Lloyds Banking Group | 47.04B |
NatWest Group | 42.51B |
3i Group | 39.95B |
Standard Chartered | 31.40B |
Prudential | 24.13B |